HBV
HBV inhibitors are compounds designed to target and inhibit various stages of the Hepatitis B virus (HBV) lifecycle. These inhibitors can interfere with viral replication, assembly, or release, thereby reducing the viral load and helping to manage chronic HBV infections. Research into HBV inhibitors is crucial for developing effective antiviral therapies to prevent liver disease and cancer associated with HBV. At CymitQuimica, we offer a range of HBV inhibitors to support your research in virology, antiviral drug development, and infectious disease management.
Found 187 products of "HBV"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
(S)-Tenofovir
CAS:(S)-Tenofovir ((S)-PMPA) is the less active S-enantiomer of Tenofovir which is a nucleotide reverse transcriptase inhibitor.Formula:C9H14N5O4PPurity:99.9%Color and Shape:SolidMolecular weight:287.21Ibandronic acid
CAS:Ibandronic acid (Bonviva) is a third-generation amino-bisphosphonate with anti-resorptive and anti-hypercalcemic activities.Formula:C9H23NO7P2Purity:94.84%Color and Shape:White Semi-SolidMolecular weight:319.23Helioxanthin 8-1
CAS:Helioxanthin 8-1, an analogue of helioxanthin, exhibits significant in vitro anti-HBV/HCV/HSV-1/HIV activity with EC50 of >5/10/1.4/15 μM.Formula:C20H12N2O6Purity:98%Color and Shape:SolidMolecular weight:376.32KKJ00626
CAS:KKJ00626, an inhibitor of HBV virus, inhibits HBV replication in transfected Huh7 cells.Formula:C7H8N4SPurity:98%Color and Shape:SolidMolecular weight:180.23BA38017
CAS:BA38017 is a potent assembly modulator of HBV core protein that inhibits the replication of HBV (EC50 = 0.20 μM) [1].Formula:C15H11ClFNO3Color and Shape:SolidMolecular weight:307.7Bay 41-4109
CAS:BAY 41-4109 is a potent inhibitor of human hepatitis B virus (HBV)(IC50 : 53 nM).Formula:C18H13ClF3N3O2Color and Shape:SolidMolecular weight:395.76Inarigivir
CAS:Inarigivir (ORI-9020) is a dinucleotide that can significantly reduce liver HBV DNA.Formula:C20H26N7O10PSPurity:98%Color and Shape:SolidMolecular weight:587.5Z060228
CAS:Z060228 is a potent anti-HBV agent, halts HBV DNA replication, and disrupts Cp149 self-assembly.Formula:C20H15ClF4N2O2Purity:98%Color and Shape:SolidMolecular weight:426.79Clevudine triphosphate
CAS:Clevudine triphosphate is a TTP analog that is able to inhibit protein priming independently of the deoxynucleoside triphosphate substrate.Formula:C10H16FN2O14P3Purity:98%Color and Shape:SolidMolecular weight:500.16HBV-IN-9
CAS:HBV-IN-9 inhibits HBsAg (IC50: 10 nM) and HBV DNA replication (IC50: 0.15 nM) per WO2018001952A1.Formula:C22H24FN7OColor and Shape:SolidMolecular weight:421.47Ruzotolimod
CAS:Ruzotolimod, an agonist of TLR7, exhibits promising potential for investigating HBV, COVID-19, and SARS-CoV-2 infections （WO2021130195A1）[1].Formula:C14H18N4O5SColor and Shape:SolidMolecular weight:354.38Canocapavir
CAS:Canocapavir (ZM-H1505R) is an HBV coat protein modulator with antiviral activity for the treatment of hepatitis B virus.Formula:C27H21BrFN5O3Purity:98.4% - 98.87%Color and Shape:SolidMolecular weight:562.39HBV-IN-7
CAS:HBV-IN-6 is a potent inhibitor of HBV (EC50: 5 nM).Formula:C18H17ClFN3O5S2Color and Shape:SolidMolecular weight:473.93trans-ccc_R08
CAS:trans-ccc_R08: potent cccDNA inhibitor, IC50 0.08 µM, may help research HBV.Formula:C22H19ClO6Color and Shape:SolidMolecular weight:414.84LP10
CAS:LP10 is a reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1 and a Potent type II inhibitor of Trypanosoma cruzi CYP51.Formula:C24H28N4O2Color and Shape:SolidMolecular weight:404.5DVR-01
CAS:DVR-01 is an HBV capsid inhibitor and can be used in studies about the treatment of Hepatitis B virus (HBV) infection and related conditions.
Formula:C20H23ClN2O3SPurity:99.95%Color and Shape:SolidMolecular weight:406.93Lagociclovir
CAS:Lagociclovir (MIV-210), a nucleoside analogue antiviral, treats HBV by inhibiting its replication in liver cancer cells.Formula:C10H12FN5O3Purity:99.18% - 99.74%Color and Shape:SolidMolecular weight:269.23HBV-IN-6
CAS:HBV-IN-6 is a potent inhibitor of HBV (EC50: 44 nM).Formula:C23H21ClFN3O5S2Color and Shape:SolidMolecular weight:538.01PPT
CAS:PPT is a modulator of water-heme interactions of CYP2C9d and CYP125A1 in low-spin P450 complexes.Formula:C11H13N3Purity:98%Color and Shape:SolidMolecular weight:187.24DVR-23
CAS:DVR-23 is a potent inhibitor of HBV virus.Formula:C17H17F3N2O3SColor and Shape:SolidMolecular weight:386.39BAY39-5493
CAS:BAY39-5493 is a hepatitis B virus inhibitor and possess antiviral activity in vitro and in vivo.Formula:C17H15ClFN3O2SColor and Shape:SolidMolecular weight:379.84AB-506
CAS:AB-506: Oral HBV replication blocker, targets core protein, hinders pgRNA encapsidation, for CHB study.Formula:C21H18ClF2N5O3Color and Shape:SolidMolecular weight:461.85Rolicyprine
CAS:Rolicyprine is an antidepressant.Formula:C14H16N2O2Purity:98%Color and Shape:SolidMolecular weight:244.29Bay 41-4109 (less active enantiomer)
CAS:Bay 41-4109 less active enantiomer shows less activity than Bay 41-4109. BAY 41-4109 is a potent HBV inhibitor (IC50: 53 nM).Formula:C18H13ClF3N3O2Purity:98%Color and Shape:SolidMolecular weight:395.76HBV-IN-19
CAS:HBV-IN19 suppresses HBV, cutting HBsAg output, useful for chronic HBV study.Formula:C24H30N2O6Color and Shape:SolidMolecular weight:442.5YZ51
CAS:YZ51, a novel potent inhibitor of ribonucleotide reductase (RR), inhibits hepatitis B virus replication by targeting ribonucleotide reductase M2 protein.Formula:C16H14FNO2Color and Shape:SolidMolecular weight:271.29Selgantolimod
CAS:Selgantolimod is an effective and selective toll-like receptor 8 agonists for the treatment of the hepatitis B virus and human immunodeficiency virus infection.Formula:C14H20FN5OPurity:98%Color and Shape:SolidMolecular weight:293.34Alamifovir
CAS:Alamifovir: HBV-specific antiviral, purine analog prodrug; active against wild-type/lamivudine-resistant HBV; inhibits DNA initiation/packaging.Formula:C19H20F6N5O5PSColor and Shape:SolidMolecular weight:575.42Helioxanthin derivative 5-4-2
CAS:Helioxanthin derivative 5-4-2 （Helioxanthin 5-4-2） is an analogue of helioxanthin that shows anti-HBV activity in vitro and can be used to study HBV.Formula:C20H13NO5Purity:99.91% - 99.92%Color and Shape:SolidMolecular weight:347.32NVP018
CAS:NVP018 (BC 556) inhibits HBV, HCV, HIV-1 replication, barely affects drug transporters, and resists HCV/HIV-1 resistance development.Formula:C45H62FN5O11Color and Shape:SolidMolecular weight:868(-)-5′-Noraristeromycin
CAS:(-)-5′-Noraristeromycin is an antiviral agent.Formula:C10H13N5O3Color and Shape:SolidMolecular weight:251.24Taribavirin hydrochloride
CAS:Taribavirin HCl: oral drug targeting HCV in liver, spares red blood cells, aims to reduce anemia risk.Formula:C8H14ClN5O4Purity:98%Color and Shape:SolidMolecular weight:279.68RIG-1 modulator 1
CAS:RIG-1 modulator 1 is useful for the treatment of viral infections including influenza virus, HBV, HCV and HIV.Formula:C14H17N5OS2Purity:98%Color and Shape:SolidMolecular weight:335.45Vidarabine phosphate
CAS:Vidarabine phosphate is an adenosine monophosphate analog.Formula:C10H14N5O7PPurity:99.75%Color and Shape:White Crystalline PowderMolecular weight:347.22Ref: TM-T20048
5mg34.00€10mg44.00€1mL*10mM (DMSO)44.00€25mg84.00€50mg113.00€100mg170.00€200mg250.00€500mg427.00€Taribavirin
CAS:Taribavirin: oral drug targeting HCV in liver, spares RBCs to reduce risk of anemia.Formula:C8H13N5O4Purity:98%Color and Shape:SolidMolecular weight:243.22Bentysrepinine
CAS:Bentysrepinine, a novel anti-HBV agent, inhibits DNA-HBV and cccDNA activities for the treatment of hepatitis B virus (HBV)-infected hepatitis.Formula:C29H35N3O4Purity:98%Color and Shape:SolidMolecular weight:489.61HBV-IN-32
CAS:HBV-IN-32 is a strong cccDNA inhibitor with an IC50 of 0.14 µM against HBsAg, also halting cell growth.Formula:C22H19ClO5SColor and Shape:SolidMolecular weight:430.9cis-ccc_R08
CAS:cis-ccc_R08 infection . cis-ccc_R08 is a cccDNA (covalently closed circular DNA) inhibitor .Formula:C22H19ClO6Color and Shape:SolidMolecular weight:414.84HBV-IN-10
CAS:HBV-IN-10, an isomer of compound 6, inhibits HBsAg with EC50 between 0.1-1 μM (Patent WO2021204258A1).Formula:C23H24FN7OColor and Shape:SolidMolecular weight:433.48HBV-IN-29
CAS:HBV-IN-29 (ex8), a flavone derivative, inhibits cccDNA in HBV research.Formula:C22H19ClO6Color and Shape:SolidMolecular weight:414.84BA-53038B
CAS:BA-53038B is an HBV core protein allosteric modulator (CpAM), binding to the HAP pocket and modulating HBV capsid assembly in a distinct manner (EC50: 3.32 μM).Formula:C14H16ClNOColor and Shape:SolidMolecular weight:249.74HBV-IN-25
CAS:HBV-IN-25: oral HBV cccDNA reducer, anti-HBeAg, anti-HBV (IC50: 0.58/1.15 μM), soluble (>452 μg/mL), non-toxic.Formula:C18H14ClNO4Color and Shape:SolidMolecular weight:343.76Fosclevudine alafenamide
CAS:Fosclevudine alafenamide (Compound EIDD-02173) is an antiviral agent that acts against HBV (EC50: 1.71 μM).Formula:C22H29FN3O9PColor and Shape:SolidMolecular weight:529.45L-Fd4A
CAS:L-Fd4A (compound 36) is an adenine derivative with anti-HIV (EC50=1.5μM) and anti-HBV (EC50=1.7μM) effects, low cytotoxicity.Formula:C10H10FN5O2Color and Shape:SolidMolecular weight:251.22(5S,8R)-HBV-IN-10
CAS:'(5S,8R)-HBV-IN-10 is an EC50 0.1-1 μM HBsAg inhibitor, isomer of compound 6 from patent WO2021204258A1.Formula:C23H24FN7OColor and Shape:SolidMolecular weight:433.48Isothiafludine
CAS:Isothiafludine is a HBV virus inhibitor that dramatically reduces the HBV DNA level in cells.Formula:C18H18FN3OS2Purity:99.71%Color and Shape:SolidMolecular weight:375.48Pradefovir
CAS:Pradefovir (Remofovir) is a prodrug for chronic HBV, converting to PMEA in the liver with a Km of 60 μM and clearance of 359 ml/min.Formula:C17H19ClN5O4PPurity:97.50%Color and Shape:SolidMolecular weight:423.79Besifovir PM
Besifovir PM (LB80331 PM) is an analogue of Besifovir, a novel orally available acyclic nucleotide phosphonate for the treatment of chronic hepatitis B
Formula:C11H15N5OPurity:98.48% - 99.90%Color and Shape:SoildMolecular weight:233.27Bersacapavir
CAS:Bersacapavir (JNJ-56136379) is an in vitro modulator of hepatitis B virus capsid assembly that inhibits HBV replication.Formula:C16H14F4N4O3SPurity:98.53%Color and Shape:SolidMolecular weight:418.37Tobevibart
CAS:Tobevibart, an IgG1-lambda humanized monoclonal antibody targeting the hepatitis B virus (HBV) surface envelope protein, exhibits antiviral activity [1].Purity:98%Color and Shape:Liquid
